Skip to main content
. 2024 Feb 6;15:1336476. doi: 10.3389/fimmu.2024.1336476

Figure 2.

Figure 2

Illustration of representative findings of immunohistochemical stains for fibronectin-1 and decorin within a cohort of 19 newly diagnosed GBM tumor patient samples.